Cardiac Management of Oncology Patients

Clinical Handbook for Cardio-Oncology

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Internal Medicine, Cardiology
Cover of the book Cardiac Management of Oncology Patients by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319158082
Publisher: Springer International Publishing Publication: May 25, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319158082
Publisher: Springer International Publishing
Publication: May 25, 2015
Imprint: Springer
Language: English

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.

More books from Springer International Publishing

Cover of the book Cardiac Emergencies in Children by
Cover of the book Complex Networks in Software, Knowledge, and Social Systems by
Cover of the book Reliability Physics and Engineering by
Cover of the book Information and Communications Security by
Cover of the book French Foreign Policy in a Changing World by
Cover of the book Haptics: Science, Technology, and Applications by
Cover of the book Social Media in Politics by
Cover of the book Evolution of Destination Planning and Strategy by
Cover of the book Partition and the Practice of Memory by
Cover of the book Water-Conservation Traits to Increase Crop Yields in Water-deficit Environments by
Cover of the book Modeling Discrete Time-to-Event Data by
Cover of the book Applications of Advanced Oxidation Processes (AOPs) in Drinking Water Treatment by
Cover of the book Algorithms and Architectures for Parallel Processing by
Cover of the book SystemC and SystemC-AMS in Practice by
Cover of the book Policy Design in the European Union by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy